Credo Diagnostics Biomedical Pte. Ltd., a groundbreaking point-of-care rapid molecular diagnostic company, announced today they will attend the Medlab Middle East exhibition that will take place at the Dubai World Trade Centre from February 3 to February 6.
Credo Diagnostics Biomedical will be showcasing it product line of point-of-care molecular diagnostic solution including the VitaPCR™ platform and Influenza A&B assay, the new QubeMDx+ platform and assays, as well as the upcoming fastest auto-extractor in the world, the Purexon.
Credo Diagnostics Biomedical will be located at the booth #Z4.D29, where they will be meeting with individual practitioners, laboratory technicians, scholars, and potential business partners.
Pets can’t tell us what’s wrong, but their biology can.
April 13, 2025
In vet care, speed and accuracy save lives—no time to wait or guess. QubeMDx+™ delivers fast, lab quality PCR results in 20 minutes at the
